BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2908661)

  • 1. Different mechanisms are responsible for oncogene activation in human mammary neoplasia.
    Kraus MH; Di Fiore PP; Pierce JH; Aaronson SA
    Cancer Treat Res; 1988; 40():49-66. PubMed ID: 2908661
    [No Abstract]   [Full Text] [Related]  

  • 2. HER-2/neu oncogene amplification and expression in breast and ovarian cancers.
    Press MF; Jones LA; Godolphin W; Edwards CL; Slamon DJ
    Prog Clin Biol Res; 1990; 354A():209-21. PubMed ID: 1978943
    [No Abstract]   [Full Text] [Related]  

  • 3. A position 12-activated H-ras oncogene in all HS578T mammary carcinosarcoma cells but not normal mammary cells of the same patient.
    Kraus MH; Yuasa Y; Aaronson SA
    Proc Natl Acad Sci U S A; 1984 Sep; 81(17):5384-8. PubMed ID: 6089200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of HER-2 oncogene amplification in breast cancer by differential polymerase chain reaction from single cryosections.
    Friedrichs K; Lohmann D; Höfler H
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 64(4):209-12. PubMed ID: 7904515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of ras oncogenes preceding the onset of neoplasia.
    Kumar R; Sukumar S; Barbacid M
    Science; 1990 Jun; 248(4959):1101-4. PubMed ID: 2188364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of RI alpha subunit of cAMP-dependent protein kinase expression induces growth inhibition of human mammary epithelial cells transformed by TGF-alpha, c-Ha-ras, and c-erbB-2 genes.
    Ciardiello F; Tortora G; Pepe S; Bianco C; Baldassarre G; Ruggiero A; Bianco C; Selvam MP; Bianco AR
    Ann N Y Acad Sci; 1993 Nov; 698():102-7. PubMed ID: 7904135
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessing sequential oncogene amplification in human breast cancer.
    Janocko LE; Lucke JF; Groft DW; Brown KA; Smith CA; Pollice AA; Singh SG; Yakulis R; Hartsock RJ; Shackney SE
    Cytometry; 1995 Sep; 21(1):18-22. PubMed ID: 8529465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Function of oncogenes in neuroepithelial tumors].
    Diedrich U
    Fortschr Neurol Psychiatr; 1992 Apr; 60(4):146-53. PubMed ID: 1601384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A human oncogene of the RAS superfamily unmasked by expression cDNA cloning.
    Chan AM; Miki T; Meyers KA; Aaronson SA
    Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7558-62. PubMed ID: 8052619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Oncogenes--motors of the cancer cell].
    Schraml P
    Praxis (Bern 1994); 2004 May; 93(22):957-9. PubMed ID: 15216926
    [No Abstract]   [Full Text] [Related]  

  • 11. RAS transformation causes sustained activation of epidermal growth factor receptor and elevation of mitogen-activated protein kinase in human mammary epithelial cells.
    Martínez-Lacaci I; Kannan S; De Santis M; Bianco C; Kim N; Wallace-Jones B; Ebert AD; Wechselberger C; Salomon DS
    Int J Cancer; 2000 Oct; 88(1):44-52. PubMed ID: 10962438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogene-mediated effects on cellular gene expression.
    Aoyama A; Klemenz R
    Crit Rev Oncog; 1993; 4(1):53-94. PubMed ID: 8380052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene.
    Zhai YF; Beittenmiller H; Wang B; Gould MN; Oakley C; Esselman WJ; Welsch CW
    Cancer Res; 1993 May; 53(10 Suppl):2272-8. PubMed ID: 8097963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of the overexpression of c-erbB-2 protein in adenocarcinoma of the uterine cervix.
    Kihana T; Tsuda H; Teshima S; Nomoto K; Tsugane S; Sonoda T; Matsuura S; Hirohashi S
    Cancer; 1994 Jan; 73(1):148-53. PubMed ID: 7506116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplification of a novel v-erbB-related gene in a human mammary carcinoma.
    King CR; Kraus MH; Aaronson SA
    Science; 1985 Sep; 229(4717):974-6. PubMed ID: 2992089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of liver epithelial cells transfected with myc and/or ras oncogenes.
    Strom SC; Faust JB; Cappelluti E; Harris RB; Lalwani ND
    Dig Dis Sci; 1991 May; 36(5):642-52. PubMed ID: 2022166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms by which genes encoding growth factors and growth factor receptors contribute to malignant transformation.
    Kraus MH; Pierce JH; Fleming TP; Robbins KC; Di Fiore PP; Aaronson SA
    Ann N Y Acad Sci; 1988; 551():320-35; discussion 336. PubMed ID: 3072902
    [No Abstract]   [Full Text] [Related]  

  • 18. Transforming collaborations between ras and nuclear oncogenes.
    Ruley HE
    Cancer Cells; 1990; 2(8-9):258-68. PubMed ID: 2223387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms involving an expanding erbB/EGF receptor family of tyrosine kinases in human neoplasia.
    Di Fiore PP; Kraus MH
    Cancer Treat Res; 1992; 61():139-60. PubMed ID: 1360229
    [No Abstract]   [Full Text] [Related]  

  • 20. Down-regulation of RI alpha subunit of cAMP-dependent protein kinase induces growth inhibition of human mammary epithelial cells transformed by c-Ha-ras and c-erbB-2 proto-oncogenes.
    Ciardiello F; Pepe S; Bianco C; Baldassarre G; Ruggiero A; Bianco C; Selvam MP; Bianco AR; Tortora G
    Int J Cancer; 1993 Feb; 53(3):438-43. PubMed ID: 8094073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.